PTEN regulation by the Akt/GSK-3β axis during RANKL signaling
Authors:
- Ji Yeon NohJNJi Yeon Noh
- Ji Hye ShinJSJi Hye Shin
- Jing Jing LinJLJing Jing Lin
- Soo Young LeeSLSoo Young Lee
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Inactivation of Glycogen Synthase Kinase-3β Is Required for Osteoclast DifferentiationJournal of Biological Chemistry, 2011
- PTEN and the PI3-Kinase Pathway in CancerAnnual Review of Pathology: Mechanisms of Disease, 2009
- Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysisBritish Journal of Pharmacology, 2008
- Lifelong accumulation of bone in mice lacking Pten in osteoblastsProceedings of the National Academy of Sciences, 2007
- Cooperative Phosphorylation of the Tumor Suppressor Phosphatase and Tensin Homologue (PTEN) by Casein Kinases and Glycogen Synthase Kinase 3βJournal of Biological Chemistry, 2005
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005
- THE WNT SIGNALING PATHWAY IN DEVELOPMENT AND DISEASEAnnual Review of Cell and Developmental Biology, 2004
- The Tumor Suppressor PTEN Is Phosphorylated by the Protein Kinase CK2 at Its C TerminusJournal of Biological Chemistry, 2001
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997